The best indicator for HCA Healthcare (HCA)
We backtested 366 indicators across daily, weekly and hourly charts on real HCA Healthcare (HCA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
RSI (25)
On the weekly chart, this is the strongest risk-adjusted edge we found for HCA Healthcare (HCA) over ~15.3 years — trailing buy-and-hold by 0.2% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for HCA Healthcare (HCA) — trailing buy-and-hold by 15.6% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | RSI (25) ✓ | Weekly | 19.7% | 0.83 | -31.6% | 47.8% | 23 | -0.2% |
| 2 | Ease of Movement ✓ | Daily | 17.7% | 0.82 | -39.2% | 47.3% | 188 | -2.4% |
| 3 | Chandelier Exit ✓ | Weekly | 19.0% | 0.82 | -51.1% | 47.4% | 19 | -0.9% |
| 4 | RSI (30) ✓ | Weekly | 19.2% | 0.82 | -31.3% | 54.5% | 22 | -0.7% |
| 5 | Ulcer Index ✓ | Weekly | 14.1% | 0.81 | -29.5% | 64.7% | 17 | -5.8% |
| 6 | Chande Kroll Stop ✓ | Weekly | 21.1% | 0.8 | -43.5% | 55.6% | 27 | 1.2% |
| 7 | Coppock (fast) ✓ | Daily | 16.7% | 0.78 | -33.8% | 51.3% | 119 | -3.3% |
| 8 | QQE ✓ | Weekly | 19.7% | 0.78 | -31.5% | 52.2% | 46 | -0.1% |
| 9 | RSI (21) ✓ | Weekly | 18.4% | 0.78 | -33.8% | 54.2% | 24 | -1.5% |
| 10 | CCI (30) ✓ | Weekly | 16.9% | 0.78 | -35.3% | 42.9% | 21 | -3.0% |
| 11 | ROC (20) ✓ | Weekly | 16.8% | 0.77 | -53.2% | 55.6% | 27 | -3.1% |
| 12 | Momentum (20) ✓ | Weekly | 16.8% | 0.77 | -53.2% | 55.6% | 27 | -3.1% |
| 13 | WMA 30 Trend ✓ | Weekly | 16.1% | 0.77 | -35.3% | 57.6% | 33 | -3.8% |
| 14 | Inverse Fisher RSI ✓ | Daily | 16.0% | 0.76 | -36.8% | 47.3% | 112 | -4.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For HCA Healthcare (HCA), RSI (25) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.